A Randomized, Double-Blind, Phase III Study of the Effic

Project: Research project

Project Details

Description

A Randomized, Double-Blind, Phase III Study of the Efficacy and Safety of Gemcitabine in Combination With TH-302 Compared With Gemcitabine
StatusFinished
Effective start/end date5/1/135/30/18

Funding

  • EMD Serono, Inc.

Fingerprint Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.